ascendis pharma financials：Quarterly Reports
Quarterly Reports
QuarterlyReports·2023·2022·2021·2020·2019·2018.。其他文章還包含有：「11.07.23PressRelease」、「AnnualReport2021」、「AscendisPharmaASAnnualReport2022」、「AscendisPharmaASAnnualRepo·rt2022」、「AscendisPharmaASReportsFullYear2021Financial...」、「AscendisPharmaReportsFirstQuarter2023Financial...」、「AscendisPharmaReportsFullYear2022Results」、「AscendisPharmaReportsSecondQuarter2023Financial....
查看更多 離開網站
11.07.23 Press Release
https://investors.ascendisphar
(Nasdaq: ASND) today announced financial results for the third quarter ended September 30, 2023 and ... regarding 2023 SKYTROFA revenues; (vi) ...
Annual Report 2021
https://investors.ascendisphar
We have audited the consolidated financial statements and the parent financial statements of Ascendis. Pharma A/S for the financial year January ...
Ascendis Pharma AS Annual Report 2022
https://www.annualreports.com
We have audited the consolidated financial statements and the parent financial statements of Ascendis. Pharma A/S for the financial year January 1 - December 31 ...
Ascendis Pharma AS Annual Repo·rt 2022
https://investors.ascendisphar
The Board of Directors and the Executive Board have today considered and approved the annual report of. Ascendis Pharma A/S for the financial year January 1 to ...
Ascendis Pharma AS Reports Full Year 2021 Financial ...
https://investors.ascendisphar
Ascendis Pharma A/S Reports Full Year 2021 Financial Results and Provides a Business Update ; Revenue, 7,778, 6,953 ; Cost of sales, 3,523, -.
Ascendis Pharma Reports First Quarter 2023 Financial ...
https://investors.ascendisphar
Ascendis Pharma Reports First Quarter 2023 Financial Results ; Revenue, 33,589, 6,828 ; Cost of sales, 4,621, 4,246 ; Gross profit, 28,968, 2,582.
Ascendis Pharma Reports Full Year 2022 Results
https://investors.ascendisphar
For the full year 2022, Ascendis Pharma reported a net loss of €583.2 million, or €10.40 per share (basic and diluted) compared to a net loss of ...
Ascendis Pharma Reports Second Quarter 2023 Financial ...
https://investors.ascendisphar
Ascendis Pharma Reports Second Quarter 2023 Financial Results ; Revenue, 47,393, 6,160 ; Cost of sales, 12,929, 1,086 ; Gross profit, 34,464, 5,074 ...
Ascendis Pharma Reports Third Quarter 2023 Financial ...
https://investors.ascendisphar
07, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the third quarter ended September 30 ...